Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Robbe Salembier

Awards & Distinctions

7 Results

2025

Transcriptomic heterogeneity of nine complementary mouse TNBC models based on their comparative in vitro and in vivo characterization

Robbe SalembierCaro De HaesBo WylinKristel DemeyereSteven Van LaereNiek SandersEvelyne MeyerJonas Steenbrugge

2024

Chitin-mediated blockade of chitinase-like proteins reduces tumor growth and immunosuppression in a mouse model for TNBC

Robbe SalembierCaro De HaesBo WylinKristel DemeyereNiek SandersEvelyne MeyerJonas Steenbrugge

Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models

Robbe SalembierCaro De HaesJulie BellemansKristel DemeyereWim Van Den BroeckNiek SandersSteven Van LaereTraci R. LyonsEvelyne MeyerJonas Steenbrugge

A1 Journal Article in BREAST CANCER RESEARCH

Comparative profiling of mouse TNBC models with differential TME states that mimic clinical heterogeneity

Robbe SalembierCaro De HaesBo WylinKristel DemeyereEvelyne MeyerJonas Steenbrugge

Lipocalin-2 blockade enhances anti-PD-1 efficacy in an immunosuppressed mouse TNBC model

Caro De HaesRobbe SalembierBo WylinKristel DemeyereEvelyne MeyerJonas Steenbrugge

Lipocalin-2 blockade reduces tumor growth and neutrophil infiltration in a mouse model for TNBC

Caro De HaesRobbe SalembierBo WylinKristel DemeyereNiek SandersEvelyne MeyerJonas Steenbrugge

2023

Chitinase 3-like 1 stimulates macrophage-mediated lymphatic remodeling in triple-negative breast cancer

Jonas SteenbruggeRobbe SalembierAlan M. ElderEvelyne MeyerTraci R. Lyons